Biopharma Compliance – Will Trump Bring an End to Regulations?

by Michaeline Daboul | Mar 2, 2017 | FCPA, UK Bribery Act, US Regulatory Compliance

Michaeline Daboul, Matthew Stephenson, and Linda D. Bentley are interviewed by Bloomberg BNA’s John T. Aquino. Learn what experts in the life sciences industry are saying about biopharma compliance to foreign bribery laws and the US FCPA in the age of Trump.